Both methods share complementary mechanisms that can enhance appetite suppression, improve glycemic control, and promote fat utilization
Alcohol Use Disorder Outcomes A national cohort study in Denmark of 38,454 individuals showed that GLP-1 medications were associated with a reduced risk of alcohol-related outcomes after three months of treatment, which included fewer hospitalizations, registered alcohol use disorder treatment, and purchase of medications to manage alcohol withdrawal (Wium-Andersen et al., 2022)
This medication is offered as part of a broader, clinically supervised weight management program that prioritizes patient education, metabolic health and individualized care
This helps you feel full sooner and stay full longer, making it easier to reduce your calorie intake and stick to a healthier lifestyle
Goal: Drive meaningful weight loss (up to ~15% of body weight) and stronger metabolic markers through GLP-1 receptor agonism [2] [5]
The prevalence of teen obesity in the U.S